371 related articles for article (PubMed ID: 18956999)
1. Therapeutic drug monitoring of phenytoin in critically ill patients.
von Winckelmann SL; Spriet I; Willems L
Pharmacotherapy; 2008 Nov; 28(11):1391-400. PubMed ID: 18956999
[TBL] [Abstract][Full Text] [Related]
2. Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children.
Wolf GK; McClain CD; Zurakowski D; Dodson B; McManus ML
Pediatr Crit Care Med; 2006 Sep; 7(5):434-9; quiz 440. PubMed ID: 16885794
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management.
Dasgupta A
Clin Chim Acta; 2007 Feb; 377(1-2):1-13. PubMed ID: 17026974
[TBL] [Abstract][Full Text] [Related]
4. [Severe phenytoin intoxication in patients with hypoalbuminaemia].
Kemper EM; van Kan HJ; Speelman P; de Gans K; Beijnen JH; Schellens JH
Ned Tijdschr Geneeskd; 2007 Jan; 151(2):138-41. PubMed ID: 17315493
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study.
Ebid AH; Ahmed MM; Mohammed SA
Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887
[TBL] [Abstract][Full Text] [Related]
6. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
Joerger M; Huitema AD; Boogerd W; van der Sande JJ; Schellens JH; Beijnen JH
Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):133-40. PubMed ID: 16918714
[TBL] [Abstract][Full Text] [Related]
7. Dosing and therapeutic monitoring of phenytoin in young adults after neurotrauma: are current practices relevant?
Frend V; Chetty M
Clin Neuropharmacol; 2007; 30(6):362-9. PubMed ID: 18090462
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of plasma free phenytoin measurement and factors influencing its protein binding.
Iwamoto T; Kagawa Y; Naito Y; Kuzuhara S; Okuda M
Biopharm Drug Dispos; 2006 Mar; 27(2):77-84. PubMed ID: 16308884
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical seizures in phenytoin toxicity.
Chua HC; Venketasubramanian N; Tan CB; Tjia H
Singapore Med J; 1999 Apr; 40(4):276-7. PubMed ID: 10487084
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug monitoring of antiepileptic drugs.
Shakya G; Malla S; Shakya KN; Shrestha R
JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
[TBL] [Abstract][Full Text] [Related]
11. High unbound fraction of valproic acid in a hypoalbuminemic critically ill patient on renal replacement therapy.
de Maat MM; van Leeuwen HJ; Edelbroek PM
Ann Pharmacother; 2011 Mar; 45(3):e18. PubMed ID: 21325101
[TBL] [Abstract][Full Text] [Related]
12. Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies.
Patsalos PN; Berry DJ; Bourgeois BF; Cloyd JC; Glauser TA; Johannessen SI; Leppik IE; Tomson T; Perucca E
Epilepsia; 2008 Jul; 49(7):1239-76. PubMed ID: 18397299
[TBL] [Abstract][Full Text] [Related]
13. Phenytoin-oxacillin interactions in normal and uremic sera.
Dasgupta A; Sperelakis A; Mason A; Dean R
Pharmacotherapy; 1997; 17(2):375-8. PubMed ID: 9085332
[TBL] [Abstract][Full Text] [Related]
14. Dilantin jeopardy: avoiding the dangers of phenytoin.
Schlicher ML
Medsurg Nurs; 1998 Dec; 7(6):343-7, 356. PubMed ID: 10036438
[TBL] [Abstract][Full Text] [Related]
15. Plasma protein binding of phenytoin in health and disease: relevance to therapeutic drug monitoring.
Perucca E
Ther Drug Monit; 1980; 2(4):331-44. PubMed ID: 7013166
[TBL] [Abstract][Full Text] [Related]
16. Correlation of Free and Total Phenytoin Serum Concentrations in Critically Ill Patients.
Buckley MS; Reeves BA; Barletta JF; Bikin DS
Ann Pharmacother; 2016 Apr; 50(4):276-81. PubMed ID: 26783351
[TBL] [Abstract][Full Text] [Related]
17. Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data.
Battino D; Croci D; Mamoli D; Messina S; Perucca E
Epilepsy Res; 2004; 59(2-3):155-65. PubMed ID: 15246117
[TBL] [Abstract][Full Text] [Related]
18. Serum free levels and evaluation anticonvulsant drug interactions.
Reynolds NC; Murthy VS
Wis Med J; 1989 Dec; 88(12):25-7. PubMed ID: 2515661
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic drug monitoring and pharmacokinetic dose prediction methods.
Oellerich M
Wien Klin Wochenschr Suppl; 1992; 191():12-5. PubMed ID: 1509745
[TBL] [Abstract][Full Text] [Related]
20. Undetectable phenytoin serum levels by an automated particle-enhanced turbidimetric inhibition immunoassay in a patient with monoclonal IgM lambda.
Brauchli YB; Scholer A; Schwietert M; Krähenbühl S
Clin Chim Acta; 2008 Mar; 389(1-2):174-6. PubMed ID: 18082631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
